GENEVA, April 6 -- REPUDIO AB (Amiralsgatan 27211 55 Malmo) filed a patent application (PCT/EP2025/077724) for "IMMUNOTHERAPY USING GGTA AND NAP" on Sep 26, 2025. With publication no. WO/2026/068773, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KORSGREN, Olov (c/o Repudio ABAmiralsgatan 27211 55 Malmo), ESSAND, Magnus (c/o Repudio ABAmiralsgatan 27211 85 Malmo), YU, Di (c/o Repudio ABAmiralsgatan 27211 85 Malmo)
Abstract: The present invention relates to a vector, such as a viral vector, comprising a first nucleic aci...